Advertisement

Antiretroviral drug resistance mutations among treated and treatment naïve patients in Pakistan: Diversity of HIV-1 pol gene in Pakistan.

01:25 EDT 20th June 2013 | BioPortfolio

Summary of "Antiretroviral drug resistance mutations among treated and treatment naïve patients in Pakistan: Diversity of HIV-1 pol gene in Pakistan."

Background: Pakistan is experiencing a growing HIV epidemic. Antiretroviral drugs (ARV) have been smuggled into the country without prescriptions since the early 1990s, but are now provided free of cost by the government. We assessed the prevalence of HIV-1 drug resistance and subtype distributions. Methods: Blood specimens were collected from HIV-1-infected participants registered in Sindh Province on dry blood spot (DBS) card in 2008. Pol, protease and partial reverse transcriptase regions were sequenced after reverse transcriptase PCR (RT-PCR). HIV-1 subtype was assigned by phylogenetic analysis. Primary drug resistance was analyzed by the Calibrated Population Resistance (CPR) tool using Stanford Surveillance Drug Resistance Mutation (SDRM) major mutation list. Results:Out of 100 blood samples collected, 42 were suitable for testing. Out of 42, 11 were ARV experience and 31 ARV naïve patients. Among them, 24 were injection drug users (IDUs), four immigrants, two hijras (male transvestites), two men who have sex with men (MSM), four prisoners, one female sex workers, two spouses of HIV-infected persons and four from the general population. ARV resistance among naïve patients was 2/31 (6.5%) and 36.4% (4/11) among ARV experienced patients making an overall resistance of 14.2%. HIV-1 was the predominant sub type found in 35/42 (83.3%) followed by CRFG_AD and C 6.5% each respectively. D, C and G were found in one (2.4%) each respectively. Conclusions: A significant proportion of Pakistani HIV patients have drug resistance. Physicians treating patients should consider the magnitude of drug resistance while selecting regimens, and address drug adherence aggressively.

Affiliation

Bridge Consultants Foundation, Karachi, Hong Kong; drsharafshah@yahoo.com.

Journal Details

This article was published in the following journal.

Name: AIDS research and human retroviruses
ISSN: 1931-8405
Pages:

Links

Medical and Biotech [MESH] Definitions

Drug Resistance, Multiple, Fungal

The ability of fungi to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance phenotype may be attributed to multiple gene mutations.

Antiretroviral Therapy, Highly Active

Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.

Drug Therapy, Computer-assisted

Adjunctive computer programs in providing drug treatment to patients.

Drug Resistance

Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration.

Thyroid Hormone Resistance Syndrome

An inherited autosomal recessive trait, characterized by peripheral resistance to THYROID HORMONES and the resulting elevation in serum levels of THYROXINE and TRIIODOTHYRONINE. This syndrome is caused by mutations of gene THRB encoding the THYROID HORMONE RECEPTORS BETA in target cells. HYPOTHYROIDISM in these patients is partly overcome by the increased thyroid hormone levels.

PubMed Articles [ 52376 Associated PubMed Articles listed on BioPortfolio]

Assessing subtype and drug-resistance-associated mutations among antiretroviral-treated HIV-infected patients.

BACKGROUND: Several studies have reported an increasing number of therapeutic failures with antiretroviral drugs in HIV-infected patients. The emergence of viral-resistant strains is a major problem f...

Scale-up of antiretroviral treatment in sub-Saharan Africa is accompanied by increasing HIV-1 drug resistance mutations in drug-naive patients.

: To evaluate the frequency and progression over time of the WHO-defined transmitted HIV-1 drug resistance mutations (DRMs) among antiretroviral treatment (ART)-naive HIV-1-infected patients in Camero...

Presence of drug resistance mutations among drug-naive patients in Morocco.

The aim of the present study was to determine viral subtypes and resistance mutations to antiretroviral treatment (ART) in HIV-1-infected treatment-naive patients from Rabat, Morocco during the period...

HIV-1 Virological Response and Prevalence of HIV-1 Drug Resistance among Patients Receiving Antiretroviral Therapy, Shandong, China.

Shandong province has been providing antiretroviral therapy (ART) to eligible HIV/AIDS patients since 2003 using first-line regimens. We conducted a cross-sectional study to assess virological respons...

HIV-1 subtypes based on the pol gene and drug resistance mutations among antiretroviral-naive patients from Guangxi, Southern China.

To investigate the distribution of HIV-1 subtypes and prevalence of HIV-1 drug resistance among HIV-infected antiretroviral-naive patients in Guangxi, southern China. 144 subjects from Liuzhou or Nann...

Clinical Trials [ 5083 Associated Clinical Trials listed on BioPortfolio]

An Evaluation of the Development of Nevirapine Induced Mutations in HIV Patients Initiating or Discontinuing Combination Antiretroviral Therapy

Hypothesis Nevirapine resistance developed in women and infants in the HIVNET 006 and 012 cohorts as a consequence of use of an agent with a long t½ as monotherapy in individuals with hi...

Development of Resistance Mutations in Pregnant HIV-Positive (+) Women Following Perinatal Antiretroviral Therapy in Israel

It has been shown that treatment of HIV-positive women with antiretroviral medication during pregnancy reduces the risk of HIV transmission to the child. However, such treatment could lead...

Genotypic Resistant HIV Strains in Taiwan

Based on the investigators previous study, seventy-four of 786 HIV-1 isolates (9.4%), collected between 1999 to 2006, harbored one or more primary mutations associated with antiretroviral...

Phase 2 Safety and Efficacy Study of Bevirimat Functional Monotherapy in HIV Treatment-Experienced Patients for 2 Weeks*

The purpose of this study is to evaluate antiretroviral activity of up to five different oral doses administered for two weeks of bevirimat versus placebo in HIV treatment experienced pati...

The Detection of Drug-Resistant HIV-1 in Taiwan

To assess the HIV resistance rate to variable antiretroviral agents in Taiwan, especially in patients with treatment failure, and to know the correlation between the drug resistance patter...

Search BioPortfolio: